A detailed history of Prudential Financial Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 24,391 shares of SRPT stock, worth $2.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,391
Previous 8,544 185.48%
Holding current value
$2.9 Million
Previous $1.35 Million 125.8%
% of portfolio
0.0%
Previous 0.0%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$124.33 - $156.75 $1.97 Million - $2.48 Million
15,847 Added 185.48%
24,391 $3.05 Million
Q2 2024

Aug 13, 2024

BUY
$113.33 - $163.85 $723,838 - $1.05 Million
6,387 Added 296.11%
8,544 $1.35 Million
Q1 2024

May 14, 2024

SELL
$93.7 - $141.53 $18,365 - $27,739
-196 Reduced 8.33%
2,157 $279,000
Q4 2023

Feb 13, 2024

SELL
$67.31 - $124.76 $673 - $1,247
-10 Reduced 0.42%
2,353 $226,000
Q3 2023

Nov 13, 2023

SELL
$102.5 - $123.59 $10,250 - $12,359
-100 Reduced 4.06%
2,363 $286,000
Q2 2023

Aug 11, 2023

SELL
$106.4 - $157.19 $1.7 Million - $2.52 Million
-16,000 Reduced 86.66%
2,463 $282,000
Q1 2023

May 12, 2023

BUY
$117.53 - $155.99 $1.79 Million - $2.37 Million
15,200 Added 465.83%
18,463 $2.54 Million
Q4 2022

Feb 14, 2023

SELL
$100.86 - $132.13 $1.98 Million - $2.59 Million
-19,611 Reduced 85.73%
3,263 $0
Q3 2022

Nov 04, 2022

SELL
$75.71 - $119.24 $4.47 Million - $7.05 Million
-59,100 Reduced 72.1%
22,874 $2.51 Million
Q2 2022

Aug 15, 2022

SELL
$62.69 - $88.44 $19.7 Million - $27.8 Million
-314,100 Reduced 79.3%
81,974 $6.32 Million
Q1 2022

May 13, 2022

BUY
$63.15 - $90.42 $23.4 Million - $33.5 Million
370,902 Added 1473.47%
396,074 $30.9 Million
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $1.75 Million - $2.26 Million
22,700 Added 918.28%
25,172 $2.27 Million
Q3 2021

Nov 15, 2021

SELL
$65.97 - $92.48 $13,194 - $18,496
-200 Reduced 7.49%
2,472 $214,000
Q2 2021

Aug 16, 2021

SELL
$69.38 - $86.75 $3,052 - $3,817
-44 Reduced 1.62%
2,672 $207,000
Q1 2021

May 12, 2021

SELL
$72.25 - $168.95 $3.26 Million - $7.63 Million
-45,181 Reduced 94.33%
2,716 $202,000
Q4 2020

Feb 16, 2021

BUY
$125.56 - $178.74 $6 Million - $8.54 Million
47,794 Added 46401.94%
47,897 $8.17 Million
Q3 2020

Aug 05, 2021

SELL
$127.12 - $172.34 $5.06 Million - $6.85 Million
-39,767 Reduced 99.74%
103 $14,000
Q3 2020

Nov 16, 2020

BUY
$127.12 - $172.34 $5.06 Million - $6.86 Million
39,816 Added 73733.33%
39,870 $5.6 Million
Q2 2020

Aug 05, 2021

SELL
$93.0 - $171.7 $3.46 Million - $6.39 Million
-37,236 Reduced 99.86%
54 $9,000
Q2 2020

Aug 12, 2020

BUY
$93.0 - $171.7 $3.46 Million - $6.39 Million
37,225 Added 57269.23%
37,290 $5.98 Million
Q1 2020

Aug 05, 2021

SELL
$82.38 - $131.64 $3.9 Million - $6.22 Million
-47,281 Reduced 99.86%
65 $6,000
Q1 2020

May 12, 2020

BUY
$82.38 - $131.64 $3.89 Million - $6.22 Million
47,240 Added 44566.04%
47,346 $4.63 Million
Q4 2019

Aug 05, 2021

SELL
$76.53 - $135.58 $3.66 Million - $6.48 Million
-47,810 Reduced 99.78%
106 $14,000
Q4 2019

Feb 11, 2020

BUY
$76.53 - $135.58 $3.66 Million - $6.48 Million
47,799 Added 40853.85%
47,916 $6.18 Million
Q3 2019

Aug 05, 2021

SELL
$72.81 - $156.91 $2.6 Million - $5.61 Million
-35,723 Reduced 99.67%
117 $9,000
Q3 2019

Nov 13, 2019

BUY
$72.81 - $156.91 $2.6 Million - $5.59 Million
35,645 Added 18279.49%
35,840 $2.7 Million
Q2 2019

Aug 05, 2021

SELL
$112.21 - $151.95 $395,540 - $535,623
-3,525 Reduced 94.76%
195 $30,000
Q2 2019

Aug 08, 2019

BUY
$112.21 - $151.95 $399,692 - $541,245
3,562 Added 2254.43%
3,720 $0
Q1 2019

Aug 05, 2021

SELL
$106.67 - $151.68 $2.95 Million - $4.19 Million
-27,632 Reduced 99.43%
158 $19,000
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $2.95 Million - $4.2 Million
27,696 Added 29463.83%
27,790 $0
Q4 2018

Aug 05, 2021

SELL
$97.32 - $148.76 $347,043 - $530,478
-3,566 Reduced 97.43%
94 $10,000
Q4 2018

Feb 07, 2019

SELL
$97.32 - $148.76 $973 - $1,487
-10 Reduced 0.27%
3,660 $399,000
Q3 2018

Nov 07, 2018

BUY
$115.31 - $161.51 $12,684 - $17,766
110 Added 3.09%
3,670 $0
Q2 2018

Aug 13, 2018

SELL
$71.74 - $153.69 $3.56 Million - $7.63 Million
-49,655 Reduced 93.31%
3,560 $0
Q1 2018

May 04, 2018

BUY
$54.02 - $82.27 $2.57 Million - $3.91 Million
47,500 Added 831.15%
53,215 $0
Q4 2017

Feb 13, 2018

SELL
$47.64 - $56.75 $6,669 - $7,945
-140 Reduced 2.39%
5,715 $318,000
Q3 2017

Nov 02, 2017

BUY
$35.73 - $47.15 $209,199 - $276,063
5,855
5,855 $266,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.